Your browser doesn't support javascript.
loading
Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy.
Li, Yan; Yang, Chen; Liu, Zhicheng; Du, Shangce; Can, Susan; Zhang, Hailin; Zhang, Linmeng; Huang, Xiaowen; Xiao, Zhenyu; Li, Xiaobo; Fang, Jingyuan; Qin, Wenxin; Sun, Chong; Wang, Cun; Chen, Jun; Chen, Huimin.
Afiliación
  • Li Y; State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Institute of Digestive Disease; Renji Hospital, Shanghai Jiao Tong University School of Medicine, 145 Middle Shandong R
  • Yang C; Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
  • Liu Z; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200001, China.
  • Du S; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Can S; Immune Regulation in Cancer Group, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
  • Zhang H; Immune Regulation in Cancer Group, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
  • Zhang L; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200001, China.
  • Huang X; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200001, China.
  • Xiao Z; State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Institute of Digestive Disease; Renji Hospital, Shanghai Jiao Tong University School of Medicine, 145 Middle Shandong R
  • Li X; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Fang J; State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Institute of Digestive Disease; Renji Hospital, Shanghai Jiao Tong University School of Medicine, 145 Middle Shandong R
  • Qin W; State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Institute of Digestive Disease; Renji Hospital, Shanghai Jiao Tong University School of Medicine, 145 Middle Shandong R
  • Sun C; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200001, China.
  • Wang C; Immune Regulation in Cancer Group, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany. c.sun@dkfz.de.
  • Chen J; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200001, China. cwang@shsci.org.
  • Chen H; Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China. chenjun23@mail.sysu.edu.cn.
Mol Cancer ; 21(1): 2, 2022 01 02.
Article en En | MEDLINE | ID: mdl-34980132

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pruebas Genéticas / Genómica / Repeticiones Palindrómicas Cortas Agrupadas y Regularmente Espaciadas / Sistemas CRISPR-Cas / Oncología Médica Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pruebas Genéticas / Genómica / Repeticiones Palindrómicas Cortas Agrupadas y Regularmente Espaciadas / Sistemas CRISPR-Cas / Oncología Médica Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article